JP2008543836A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008543836A5 JP2008543836A5 JP2008516935A JP2008516935A JP2008543836A5 JP 2008543836 A5 JP2008543836 A5 JP 2008543836A5 JP 2008516935 A JP2008516935 A JP 2008516935A JP 2008516935 A JP2008516935 A JP 2008516935A JP 2008543836 A5 JP2008543836 A5 JP 2008543836A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- pharmaceutical composition
- group
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 25
- 150000001875 compounds Chemical class 0.000 claims 22
- 230000000840 anti-viral effect Effects 0.000 claims 16
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 150000003839 salts Chemical class 0.000 claims 14
- 125000003710 aryl alkyl group Chemical group 0.000 claims 13
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 11
- 125000003342 alkenyl group Chemical group 0.000 claims 10
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 9
- 210000004027 cell Anatomy 0.000 claims 9
- 241000725303 Human immunodeficiency virus Species 0.000 claims 8
- 125000003118 aryl group Chemical group 0.000 claims 8
- 125000004432 carbon atom Chemical group C* 0.000 claims 7
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 208000030507 AIDS Diseases 0.000 claims 6
- 125000000623 heterocyclic group Chemical group 0.000 claims 6
- 229910052801 chlorine Inorganic materials 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 239000000126 substance Substances 0.000 claims 5
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 125000000304 alkynyl group Chemical group 0.000 claims 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 229910052731 fluorine Inorganic materials 0.000 claims 4
- 125000002541 furyl group Chemical group 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 208000015181 infectious disease Diseases 0.000 claims 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 4
- 125000004076 pyridyl group Chemical group 0.000 claims 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 4
- 229940079593 drug Drugs 0.000 claims 3
- 229910052740 iodine Inorganic materials 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 claims 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 2
- 230000002924 anti-infective effect Effects 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 claims 2
- 229960001438 immunostimulant agent Drugs 0.000 claims 2
- 239000003022 immunostimulating agent Substances 0.000 claims 2
- 230000003308 immunostimulating effect Effects 0.000 claims 2
- -1 methoxy, ethoxy, propoxy, butoxy, pentoxy Chemical group 0.000 claims 2
- 125000001624 naphthyl group Chemical group 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 230000010076 replication Effects 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 1
- 239000002259 anti human immunodeficiency virus agent Substances 0.000 claims 1
- 230000036436 anti-hiv Effects 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69112005P | 2005-06-15 | 2005-06-15 | |
| PCT/US2006/021993 WO2006138118A2 (en) | 2005-06-15 | 2006-06-06 | Anti-viral compositions comprising heterocyclic substituted phenyl furans and related compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008543836A JP2008543836A (ja) | 2008-12-04 |
| JP2008543836A5 true JP2008543836A5 (enExample) | 2009-07-23 |
Family
ID=37570970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008516935A Withdrawn JP2008543836A (ja) | 2005-06-15 | 2006-06-06 | 複素環置換フェニルフランおよび関連化合物を含む抗ウイルス組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20060287319A1 (enExample) |
| EP (1) | EP1896033A4 (enExample) |
| JP (1) | JP2008543836A (enExample) |
| CA (1) | CA2608821A1 (enExample) |
| WO (1) | WO2006138118A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12012502411A1 (en) | 2005-05-10 | 2019-07-17 | Intermune Inc | Method of modulating stress-activated protein kinase system |
| US20070099970A1 (en) * | 2005-08-19 | 2007-05-03 | Mackerell Alexander | Immunomodulatory compounds that target and inhibit the pY'binding site of tyrosene kinase p56 LCK SH2 domain |
| CN101990534A (zh) * | 2007-11-01 | 2011-03-23 | Uab研究基金会 | 治疗和预防病毒感染 |
| US8304413B2 (en) | 2008-06-03 | 2012-11-06 | Intermune, Inc. | Compounds and methods for treating inflammatory and fibrotic disorders |
| US8455516B2 (en) * | 2010-01-15 | 2013-06-04 | Touro University | HIV-1 fusion inhibitors and methods |
| AR081930A1 (es) | 2010-06-16 | 2012-10-31 | Ardea Biosciences Inc | Compuestos de tioacetato |
| EP2590971A4 (en) * | 2010-06-17 | 2014-12-10 | Fuzians Biomedicals Inc | COMPOUNDS SUITABLE FOR ANTIVIRAL ACTIVE SUBSTANCES, COMPOSITIONS AND METHOD OF USE THEREOF |
| US9023876B2 (en) * | 2010-07-08 | 2015-05-05 | Adhaere Pharmaceuticals, Inc. | Compounds and methods for regulating integrins |
| EP2838614B1 (en) | 2012-04-20 | 2019-09-11 | GB006, Inc. | Compositions for regulating integrins |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| CN103724337A (zh) * | 2012-10-15 | 2014-04-16 | 南京大学 | 一类含萘环和噻唑啉酮结构的吡唑啉类衍生物及其制法 |
| RU2692485C2 (ru) | 2014-04-02 | 2019-06-25 | Интермьюн, Инк. | Противофиброзные пиридиноны |
| WO2020006494A1 (en) | 2018-06-29 | 2020-01-02 | Fred Hutchinson Cancer Research Center | Cell-stored barcoded deep mutational scanning libraries and uses of the same |
| CN111747944B (zh) * | 2020-07-13 | 2022-09-30 | 复旦大学 | 广谱抗包膜病毒化合物、组合物及其应用 |
| WO2022225572A1 (en) * | 2021-04-22 | 2022-10-27 | New York Blood Center, Inc. | Respiratory virus inhibitors |
| CN115444846A (zh) * | 2022-09-01 | 2022-12-09 | 中国人民解放军军事科学院军事医学研究院 | HIV-1Tat蛋白抑制剂及其应用 |
| CN119174759A (zh) * | 2023-06-21 | 2024-12-24 | 上海科技大学 | 一种噻唑烷二酮类化合物、其药物组合物和其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU743411B2 (en) * | 1998-08-21 | 2002-01-24 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing viral infections and associated diseases |
| US20050042674A9 (en) * | 2002-02-21 | 2005-02-24 | Lin Yu | Common ligand mimics: thiazolidinediones and rhodanines |
| US20040002526A1 (en) * | 2002-04-03 | 2004-01-01 | Cell Therapeutics, Inc. | Phospholipase D inhibitors and uses thereof |
| AU2003294275A1 (en) * | 2002-11-21 | 2004-06-18 | New York Blood Center | Compounds for inhibition of hiv infection by blocking hiv entry |
| WO2005007141A2 (en) * | 2003-07-11 | 2005-01-27 | Proteologics, Inc. | Ubiquitin ligase inhibitors and methods related thereto |
| EP1654380A4 (en) * | 2003-08-14 | 2009-09-09 | Insight Biopharmaceuticals Ltd | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING HEPARANASE ACTIVATION AND USES THEREOF |
| WO2005041951A2 (en) * | 2003-10-28 | 2005-05-12 | Rigel Pharmaceuticals, Inc. | Rhodanine derivatives for use as antiviral agents |
-
2006
- 2006-06-06 WO PCT/US2006/021993 patent/WO2006138118A2/en not_active Ceased
- 2006-06-06 US US11/448,439 patent/US20060287319A1/en not_active Abandoned
- 2006-06-06 JP JP2008516935A patent/JP2008543836A/ja not_active Withdrawn
- 2006-06-06 EP EP06772346A patent/EP1896033A4/en not_active Withdrawn
- 2006-06-06 CA CA002608821A patent/CA2608821A1/en not_active Abandoned